RegeneRX Biopharmaceuticals Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.01 |
Market Cap |
$22.34 M |
Shares Outstanding |
131.51 M |
Public Float |
63.65 M |
Address |
15245 Shady Grove Road Rockville Maryland 20850 United States |
Employees | - |
Website | http://www.regenerx.com |
Updated | 07/08/2019 |
RegeneRx Biopharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, or Tß4, for tissue and organ protection, repair, and regeneration. The firm evaluates the commercial development of peptide fragments and derivatives of Tß4 for potential cosmeceutical and other personal care uses. Its products include RGN-259, RGN-352, and RGN-137. |